Taiwan FDA registration 8bdb0cfb5741a02a66129debdd7abbac
"Bozhi" rapid pregnancy test reagent series
TW: “博智” 快速驗孕試劑系列
Taiwan·Risk Class 2·Primus International Marketing Limited;; Dongyao Biotechnology Co., Ltd·Registered May 19, 2016 – Sep 28, 2025ExpiredRegistration details
- Analysis ID
- 8bdb0cfb5741a02a66129debdd7abbac
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BOR JYH INTERNATIONAL MARKETING CO., LTD.
Product details
- Intended Use
- The urine is tested qualitatively for human chorionic gonadotropin. New performance: Added non-professional use.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic;; Contract manufacturing
Dates and status
- Registration Date
- May 19, 2016
- Expiry Date
- Sep 28, 2025
About this record
Access comprehensive regulatory information for "Bozhi" rapid pregnancy test reagent series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8bdb0cfb5741a02a66129debdd7abbac and manufactured by Primus International Marketing Limited;; Dongyao Biotechnology Co., Ltd. The authorized representative in Taiwan is BOR JYH INTERNATIONAL MARKETING CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices